Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
Titel:
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
Auteur:
Eide, Christopher A. Zabriskie, Matthew S. Savage Stevens, Samantha L. Antelope, Orlando Vellore, Nadeem A. Than, Hein Schultz, Anna Reister Clair, Phillip Bowler, Amber D. Pomicter, Anthony D. Yan, Dongqing Senina, Anna V. Qiang, Wang Kelley, Todd W. Szankasi, Philippe Heinrich, Michael C. Tyner, Jeffrey W. Rea, Delphine Cayuela, Jean-Michel Kim, Dong-Wook Tognon, Cristina E. O'Hare, Thomas Druker, Brian J. Deininger, Michael W.